{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,2]],"date-time":"2026-08-02T13:49:18Z","timestamp":1785678558761,"version":"3.56.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2009,9,1]],"date-time":"2009-09-01T00:00:00Z","timestamp":1251763200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,9,1]],"date-time":"2009-09-01T00:00:00Z","timestamp":1251763200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T00:00:00Z","timestamp":1673395200000},"content-version":"vor","delay-in-days":4880,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["mp.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Modern Pathology"],"published-print":{"date-parts":[[2009,9]]},"DOI":"10.1038\/modpathol.2009.78","type":"journal-article","created":{"date-parts":[[2009,5,15]],"date-time":"2009-05-15T11:13:30Z","timestamp":1242386010000},"page":"1169-1175","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":132,"title":["Clinical validation of an array CGH test for HER2 status in breast cancer reveals that polysomy 17 is a rare event"],"prefix":"10.1016","volume":"22","author":[{"given":"I-Tien","family":"Yeh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathew A","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan S","family":"Robetorye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aswani R","family":"Bolla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"McCaskill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rashmi K","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mercedes E","family":"Gorre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mansoor S","family":"Mohammed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shelly R","family":"Gunn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/modpathol.2009.78_bib1","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1002\/stem.160413","article-title":"The HER-2\/neu oncogene in breast cancer: prognostic factor, predictive factor, and target for therapy","volume":"16","author":"Ross","year":"1998","journal-title":"Stem Cells"},{"key":"10.1038\/modpathol.2009.78_bib2","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1200\/JCO.2006.09.2775","article-title":"American Society of Clinical Oncology\/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer","volume":"25","author":"Wolff","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1038\/modpathol.2009.78_bib3","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1136\/jcp.2006.039602","article-title":"Amplification of the HER2 gene in breast cancers testing 2+ weak positive by HercepTest immunohistochemistry: false-positive or false-negative immunohistochemistry?","volume":"60","author":"Barrett","year":"2007","journal-title":"J Clin Pathol"},{"key":"10.1038\/modpathol.2009.78_bib4","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1136\/jcp.2006.043562","article-title":"Central HER2 IHC and FISH analysis in a trastuzumab (Herceptin) phase II monotherapy study: assessment of test sensitivity and impact of chromosome 17 polysomy","volume":"61","author":"Hofmann","year":"2008","journal-title":"J Clin Pathol"},{"key":"10.1038\/modpathol.2009.78_bib5","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1093\/jnci\/djm075","article-title":"Inconsistency of HER2 test raises questions","volume":"99","author":"Tuma","year":"2007","journal-title":"J Natl Cancer Inst"},{"key":"10.1038\/modpathol.2009.78_bib6","doi-asserted-by":"crossref","first-page":"4869","DOI":"10.1200\/JCO.2007.13.4296","article-title":"Polysomy 17 in breast cancer: clinicopathologic significance and impact on HER-2 testing","volume":"26","author":"Vanden Bempt","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1038\/modpathol.2009.78_bib7","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1023\/A:1021399923825","article-title":"Chromosome 17 aneusomy is associated with poor prognostic factors in invasive breast carcinoma","volume":"77","author":"Watters","year":"2003","journal-title":"Breast Cancer Res Treat"},{"key":"10.1038\/modpathol.2009.78_bib8","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/modpathol.3880505","article-title":"Aneusomy 17 in breast cancer: its role in HER-2\/neu protein expression and implication for clinical assessment of HER-2\/neu status","volume":"15","author":"Wang","year":"2002","journal-title":"Mod Pathol"},{"key":"10.1038\/modpathol.2009.78_bib9","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1046\/j.1524-4741.2001.21018.x","article-title":"Her-2\/neu gene amplification in low to moderately expressing breast cancers: possible role of chromosome 17\/Her-2\/neu polysomy","volume":"7","author":"Bose","year":"2001","journal-title":"Breast J"},{"key":"10.1038\/modpathol.2009.78_bib10","doi-asserted-by":"crossref","first-page":"2572","DOI":"10.1158\/1535-7163.MCT-06-0129","article-title":"Correction for chromosome-17 is critical for the determination of true Her-2\/neu gene amplification status in breast cancer","volume":"5","author":"Dal Lago","year":"2006","journal-title":"Mol Cancer Ther"},{"key":"10.1038\/modpathol.2009.78_bib11","doi-asserted-by":"crossref","first-page":"R267","DOI":"10.1186\/bcr996","article-title":"Polysomy of chromosome 17 in breast cancer tumors showing an overexpression of ERBB2: a study of 175 cases using fluorescence in situ hybridization and immunohistochemistry","volume":"7","author":"Salido","year":"2005","journal-title":"Breast Cancer Res"},{"key":"10.1038\/modpathol.2009.78_bib12","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1309\/GM16C01806EFURX7","article-title":"How is Her-2\/neu status established when Her-2\/neu and chromosome 17 centromere are both amplified?","volume":"126","author":"Press","year":"2006","journal-title":"Am J Clin Pathol"},{"key":"10.1038\/modpathol.2009.78_bib13","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1309\/9EYM6VE58F2YCD9F","article-title":"Evaluation of Her-2\/neu status in carcinomas with amplified chromosome 17 centromere locus","volume":"126","author":"Troxell","year":"2006","journal-title":"Am J Clin Pathol"},{"key":"10.1038\/modpathol.2009.78_bib14","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1002\/(SICI)1098-2264(199712)20:4<399::AID-GCC12>3.0.CO;2-I","article-title":"Matrix-based comparative genomic hybridization: biochips to screen for genomic imbalances","volume":"20","author":"Solinas-Toldo","year":"1997","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1038\/modpathol.2009.78_bib15","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/2524","article-title":"High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays","volume":"20","author":"Pinkel","year":"1998","journal-title":"Nat Genet"},{"key":"10.1038\/modpathol.2009.78_bib16","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1023\/A:1023025506386","article-title":"Profiling breast cancer by array CGH","volume":"78","author":"Albertson","year":"2003","journal-title":"Breast Cancer Res Treat"},{"key":"10.1038\/modpathol.2009.78_bib17","doi-asserted-by":"crossref","first-page":"R1186","DOI":"10.1186\/bcr1356","article-title":"High resolution genomic analysis of sporadic breast cancer using array-based comparative genomic hybridization","volume":"7","author":"Naylor","year":"2005","journal-title":"Breast Cancer Res"},{"key":"10.1038\/modpathol.2009.78_bib18","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/bcr1510","article-title":"Array-CGH and breast cancer","volume":"8","author":"van Beers","year":"2006","journal-title":"Breast Cancer Res"},{"key":"10.1038\/modpathol.2009.78_bib19","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1139\/O07-072","article-title":"Characterization of breast cancer by array comparative genomic hybridization","volume":"85","author":"Climent","year":"2007","journal-title":"Biochem Cell Biol"},{"key":"10.1038\/modpathol.2009.78_bib20","doi-asserted-by":"crossref","first-page":"528","DOI":"10.2353\/jmoldx.2006.060029","article-title":"Application of array-based comparative genomic hybridization to clinical diagnostics","volume":"8","author":"Bejjani","year":"2006","journal-title":"J Mol Diagn"},{"key":"10.1038\/modpathol.2009.78_bib21","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1073\/pnas.0304717101","article-title":"Automated array-based genomic profiling in chronic lymphocytic leukemia: development of a clinical tool and discovery of recurrent genomic alterations","volume":"101","author":"Schwaenen","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/modpathol.2009.78_bib22","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1002\/ajh.21145","article-title":"Validation of a targeted DNA microarray for the clinical evaluation of recurrent abnormalities in chronic lymphocytic leukemia","volume":"83","author":"Patel","year":"2008","journal-title":"Am J Hematol"},{"key":"10.1038\/modpathol.2009.78_bib23","doi-asserted-by":"crossref","first-page":"442","DOI":"10.2353\/jmoldx.2008.080033","article-title":"Whole-genome scanning by array comparative genomic hybridization as a clinical tool for risk assessment in chronic lymphocytic leukemia","volume":"10","author":"Gunn","year":"2008","journal-title":"J Mol Diagn"},{"key":"10.1038\/modpathol.2009.78_bib24","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/labinvest.2008.19","article-title":"Genomic analysis of the HER2\/TOP2A amplicon in breast cancer and breast cancer cell lines","volume":"88","author":"Arriola","year":"2008","journal-title":"Lab Invest"},{"key":"10.1038\/modpathol.2009.78_bib25","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/modpathol.3880267","article-title":"Preservation of RNA for functional genomic studies: a multidisciplinary tumor bank protocol","volume":"14","author":"Florell","year":"2001","journal-title":"Mod Pathol"},{"key":"10.1038\/modpathol.2009.78_bib26","series-title":"A Tumor-Targeted DNA Extraction Method for Array CGH Analysis of HER2 Gene Copy Number Status in Newly Diagnosed Breast Cancer. United States and Canadian Academy of Pathology","author":"Robetorye","year":"2009"},{"key":"10.1038\/modpathol.2009.78_bib27","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1093\/jnci\/94.11.852","article-title":"Real-world performance of HER2 testing\u2013National Surgical Adjuvant Breast and Bowel Project experience","volume":"94","author":"Paik","year":"2002","journal-title":"J Natl Cancer Inst"},{"key":"10.1038\/modpathol.2009.78_bib28","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1093\/jnci\/94.11.855","article-title":"Concordance between local and central laboratory HER2 testing in the breast intergroup trial N9831","volume":"94","author":"Roche","year":"2002","journal-title":"J Natl Cancer Inst"}],"container-title":["Modern Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/modpathol200978.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/modpathol200978","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222024681?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222024681?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/modpathol200978.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T00:59:52Z","timestamp":1760230792000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0893395222024681"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9]]},"references-count":28,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2009,9]]}},"alternative-id":["S0893395222024681"],"URL":"https:\/\/doi.org\/10.1038\/modpathol.2009.78","relation":{},"ISSN":["0893-3952"],"issn-type":[{"value":"0893-3952","type":"print"}],"subject":[],"published":{"date-parts":[[2009,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical validation of an array CGH test for HER2 status in breast cancer reveals that polysomy 17 is a rare event","name":"articletitle","label":"Article Title"},{"value":"Modern Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/modpathol.2009.78","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2009 United States & Canadian Academy of Pathology.","name":"copyright","label":"Copyright"}]}}